US 9517276
Compositions and methods for conjugating activatable antibodies
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 9517276 (Compositions and methods for conjugating activatable antibodies) held by CytomX Therapeutics, Inc. expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K47/68031, A61K47/6851